# Noramco, Inc., Wilmington, DE – FDA Inspections

Source: https://www.keypedia.com/companies/noramco-inc/8af3944b-5c06-49e7-813b-71cf3dd72be6

> Inspection records and compliance data for Noramco, Inc. in Wilmington, Delaware. 8 FDA inspections on record, 1 Form 483, last inspected October 15, 2025.

---

## Details

- Name: Noramco, Inc.
- FEI Number: 2522445
- Business Operations: API MANUFACTURE
- Address Line 1: 500 Swedes Landing Rd
- City: Wilmington
- State: Delaware
- Zip Code: 19801
- Country Name: United States
- Address: 500 Swedes Landing Rd, Wilmington, Delaware 19801, United States
- Country: United States

## Related Documents

- [483 - Noramco, Inc. - 2025-10-15](https://www.keypedia.com/records/483/noramco-inc/1cf44fe1-fbad-4617-b404-ecd0cf111ab4) — source: FDA, date: October 15, 2025
- [FDA Inspection 1287192 - Noramco, Inc. - 2025-10-15](https://www.keypedia.com/records/fda_inspections/noramco-inc/fc00164b-b83c-4ff4-922c-8e4d3e433955) — source: FDA, date: October 15, 2025
- FDA Inspection 1287192 - Noramco, Inc. - 2025-10-15 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 15, 2025
- FDA Inspection 1194573 - Noramco, Inc. - 2022-11-18 — classification: No Action Indicated (NAI), source: FDA, date: November 18, 2022
- [EIR - Noramco, Inc. - 2019-02-21](https://www.keypedia.com/records/eir/noramco-inc/7a7232bc-bdbe-4e84-bf1a-ddd121686456) — source: FDA, date: February 21, 2019
- FDA Inspection 1083841 - Noramco, Inc. - 2019-02-21 — classification: No Action Indicated (NAI), source: FDA, date: February 21, 2019
- FDA Inspection 1032329 - Noramco, Inc. - 2017-11-17 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 17, 2017
- FDA Inspection 956500 - Noramco, Inc. - 2016-01-21 — classification: No Action Indicated (NAI), source: FDA, date: January 21, 2016
- FDA Inspection 903718 - Noramco, Inc. - 2014-11-13 — classification: No Action Indicated (NAI), source: FDA, date: November 13, 2014
- FDA Inspection 778983 - Noramco, Inc. - 2012-04-27 — classification: No Action Indicated (NAI), source: FDA, date: April 27, 2012
- FDA Inspection 674165 - Noramco, Inc. - 2010-08-02 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 2, 2010

## Related Companies

- [Giles Chemical Corporation a Division of Premier Magnesia, LLC](https://www.keypedia.com/companies/giles-chemical-corporation-a-division-of-premier-magnesia-llc/850e7d68-676b-43e0-be70-e1027fe10436)
- [Univar Solutions USA Inc.](https://www.keypedia.com/companies/univar-solutions-usa-inc/5f18ce8e-0ac8-402c-b811-4c9feb72d717)
- [Gehring-Montgomery, Inc.](https://www.keypedia.com/companies/gehring-montgomery-inc/c0814822-3417-453f-a990-e9babc6b2523)
- [Bioiberica, SAU](https://www.keypedia.com/companies/bioiberica-sau/3984e671-30b1-4c37-b603-0e20b5a76b7d)
- [Cambridge Isotope Laboratories, Inc.](https://www.keypedia.com/companies/cambridge-isotope-laboratories-inc/86432a1b-751d-40d3-bf8a-9624c97f584b)
- [CIMBAR PERFORMANCE MINERALS, INC.](https://www.keypedia.com/companies/cimbar-performance-minerals-inc/de097cdd-af46-4d14-8566-45a6205d9895)
- [Evonik Active Oxygens, LLC](https://www.keypedia.com/companies/evonik-active-oxygens-llc/3f4770f9-f6d2-49a9-8b6c-84e89f10a5e6)
- [R.S.A. Corp.](https://www.keypedia.com/companies/rsa-corp/d731050b-36e3-475d-9748-8defc5556e50)
- [Ames Goldsmith Corporation](https://www.keypedia.com/companies/ames-goldsmith-corporation/0c9c7a1f-10cc-4a11-9136-632fc42dbd63)
- [Nippon Rika Co., Ltd.](https://www.keypedia.com/companies/nippon-rika-co-ltd/28d4ba43-fd16-42e5-9335-0a449b2f57eb)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/michael-a-taylor/58def2af-ec67-4537-9f67-c7e33de85ff7)
- [Investigator](https://www.keypedia.com/people/junho-pak/4abe53fb-ad20-490d-9e71-6216a9f863f5)
